2024) Zanthoxylum piperitum Attenuates Monosodium Urate-Induced Gouty Arthritis: A Network Pharmacology Investigation of Its Anti-Inflammatory Mechanisms
2024) Indigo Naturalis in Inflammatory Bowel Disease: mechanisms of action and insights from clinical trials
2024) The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease A Promising Therapeutic Approach
2023) The Evaluation of the Single-Dose Toxicity and Safety of 4-Carvomenthenol in ICR Mice
2023) Regnase-1 plays an essential role in maintaining skin immune homeostasis via regulation of chemokine expression
2023) Natural Products as the Potential to Improve Alzheimer’s and Parkinson’s Disease
2022) Verbenalin Reduces Amyloid-Beta Peptide Generation in Cellular and Animal Models of Alzheimer’s Disease
2022) Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout
2022) Loganin Prevents Hepatic Steatosis by Blocking NLRP3 Inflammasome Activation
2022) Inflammasomes and their roles in arthritic disease pathogenesis
2022) Improvement Effect of Soyeom Pharmacopuncture on Gout via NLRP3 Inflammasome Regulation
2021) Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells
2021) RIG-I Deficiency Promotes Obesity-Induced Insulin Resistance
2021) Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages
2021) Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage
2021) A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
2020) Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome
2020) Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis
2020) Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome
2020) Para-phenylenediamine, an oxidative hair dye ingredient, increases thymic stromal lymphopoietin and proinflammatory cytokines causing acute dermatitis
2020) Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis
2019) Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells
2019) Immunostimulatory activity of Y-shaped DNA nanostructures mediated through the activation of TLR9
2019) Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis
2018) Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation
2018) Potentiation of skin TSLP production by a cosmetic colorant leads to aggravation of dermatitis symptoms
2018) Phloxine O, a Cosmetic Colorant, Suppresses the Expression of Thymic Stromal Lymphopoietin and Acute Dermatitis Symptoms in Mice
2018) Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome
2018) Efficient Transdermal Delivery of DNA Nanostructures Alleviates Atopic Dermatitis Symptoms in NC Nga Mice
2018) Anti-obesity potential of Glycyrrhiza uralensis and licochalcone A through induction of adipocyte browning
2017) Suppression of Primary Splenocyte Proliferation by Artemisia capillaris and Its Components
2017) Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages
2016) Topical Application of Dieckol Ameliorates Atopic Dermatitis in NC Nga Mice by Suppressing Thymic Stromal Lymphopoietin Production
2016) Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester a novel strategy to treat acute gout
2016) A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
